AVTR
Get informed when a big investor buys or sells
+ FollowOvervalued by 21.9% based on the discounted cash flow analysis.
| Market cap | $10.60 Billion |
|---|---|
| Enterprise Value | $10.33 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.94 |
| Outstanding Shares | 676,200,000 |
| P/E Ratio | -18.68 |
|---|---|
| PEG | 45.44 |
| Price to Sales | - |
| Price to Book Ratio | 2.01 |
| Enterprise Value to Revenue | 1160.53 |
| Enterprise Value to EBIT | -39.18 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 83.98% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 104.21% |
|---|---|
| Total Invested | $4.87M▼ 99.93% |
| Investors Holding | 13▼ 457.00% |
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.